Oncol Lett 13: [Related article:] 4093-4100, 2017; DOI:
10.3892/ol.2017.5988
Following the publication of this article, we have
realized a couple of errors were included in the text, and would
like to correct these for the record (the changed text is
subsequently highlighted in bold).
First, on page 4,096, under the heading
“Treatment effectiveness” at the end of the first paragraph,
the text should have read as follows: “Similar results were
observed after 6 months. Compared with the 3 months prior to
lacosamide initiation, there was a significant reduction in total
seizures between 3 and 6 months [prior to treatment, mean
26.4, SD 50.4, median 4.0 (range 0–200); between 3 and 6
months, mean 9.4, SD 22.8, median 0.5 (range 0–100); difference
in means P<0.0001; Fig. 2].”
In addition, for Fig. 2, the y-axis title should
have read as: “Mean number of seizures over the last 3
months”, and the figure legend should have read as follows: “Mean
number of seizures in the 3 months prior to, and during, the 3–6
month period of lacosamide treatment in patients experiencing
epileptic seizures due to a brain tumor (n=26). Numbers above the
bars indicate the difference from the baseline and the
corresponding P-value (calculated using the χ2 test).
NS, not significant.”
We regret any inconvenience these mistakes have
caused.
